Data / Form D filings / Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc.: Form D filing
Telomir Pharmaceuticals, Inc., a pharmaceuticals company in Tampa, FL, filed a Form D with the SEC in 2023. The latest, on April 3, 2023, reports $1 million sold of a $1 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 900 WEST PLATT STREET, SUITE 200, Tampa, FL, 33606
- Phone
- (813) 864-2562
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Florida
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1971532
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | New notice | $1,000,000 | $1,000,000 | 10 | Mar 15, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tuck Talhia | Director | |
| Craig Eagle | Director | |
| David Vorhoff | Director | |
| James McNulty | Executive Officer | |
| Chris Chapman | Executive Officer, Director | |
| Hugh McColl | Director | |
| Jude Uzonwanne | Director |
Other pharmaceuticals companies in Florida that filed recently
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Apr 3, 2023 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Telomir Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.